These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6836956)

  • 21. [Effect in vitro of lanthanum, yttrium and cerium chlorides on the 1st phase of the thrombin-fibrinogen reaction].
    Ducastaing A; Monceyron C; Azanza JL; Creac'h P; Raymond J
    C R Seances Soc Biol Fil; 1973; 167(2):262-9. PubMed ID: 4802769
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
    Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
    Undas A; Kolarz M; Kopeć G; Tracz W
    Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XI and protection of the fibrin clot against lysis--a role for the intrinsic pathway of coagulation in fibrinolysis.
    Bouma BN; von dem Borne PA; Meijers JC
    Thromb Haemost; 1998 Jul; 80(1):24-7. PubMed ID: 9684779
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1263-71. PubMed ID: 16146462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycolaldehyde induces fibrinogen post-translational modification, delay in clotting and resistance to enzymatic digestion.
    Andrades ME; Lorenzi R; Berger M; Guimarães JA; Moreira JC; Dal-Pizzol F
    Chem Biol Interact; 2009 Aug; 180(3):478-84. PubMed ID: 19397901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of the GABA- and cholinergic systems in the formation of a dissociated state to an antioxidant of the 3-hydroxypyridine class].
    Voronina TA; Sopyev ZhA; Garibova TL; Smirnov LD
    Biull Eksp Biol Med; 1987 Jan; 103(1):66-8. PubMed ID: 3026520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases.
    Wygrecka M; Jablonska E; Guenther A; Preissner KT; Markart P
    Thromb Haemost; 2008 Mar; 99(3):494-501. PubMed ID: 18327397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An analysis of a disorder in the fibrin-forming phase in virtually healthy middle-aged and elderly subjects by using the ancistron test].
    Platonova TN; Sushko OO; Lukinova NI; Solovĭov DA
    Fiziol Zh (1994); 1994; 40(3-4):63-70. PubMed ID: 7621957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty: a prospective study.
    Duchow J; Ames M; Hess T; Seyfert U
    J Arthroplasty; 2001 Oct; 16(7):844-9. PubMed ID: 11607899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
    Flood VH; Nagaswami C; Chernysh IN; Al-Mondhiry HA; Weisel JW; Farrell DH
    Br J Haematol; 2007 Jul; 138(1):117-24. PubMed ID: 17555455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of the inhibitor-antioxidant belonging to the 3-hydroxypyridine series on immunocompetent and stem cells].
    Kapichnikov MM; Dakhina NN; Suzdal'ieva AA; Smirnov LD; Slepukhina LV
    Biull Eksp Biol Med; 1980; 89(1):42-4. PubMed ID: 6991022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography.
    Mousa SA
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):55-60. PubMed ID: 17179828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of epsilon-aminocaproylamino acids on fibrin formation.
    Bruzgo I; Midura-Nowaczek K; Bruzgo M; Kaczyńska J; Roszkowska-Jakimiec W
    Acta Pol Pharm; 2006; 63(2):149-52. PubMed ID: 17514879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.